Clinical Trial Update: Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients

View source ↗

Summary

An ongoing study evaluating 1-year outcomes after early initiation of inclisiran in patients who have had a myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Myocardial Infarction | Status: RECRUITING